Neuroendocrine Tumors of the Gastrointestinal Tract: A Focused Review and Practical Approach for Gastroenterologists
- PMID: 34604465
- PMCID: PMC8443956
- DOI: 10.1159/000512089
Neuroendocrine Tumors of the Gastrointestinal Tract: A Focused Review and Practical Approach for Gastroenterologists
Abstract
Neuroendocrine tumors (NETs) are rare tumors derived from the neuroendocrine cell system, and more commonly found in the gastrointestinal (GI) tract. Over the last decades, the incidence of GI-NETs has been steadily increasing, partly due to the expanding indications for endoscopy. Most patients with NETs are asymptomatic, and their NETs are noticed during screening examinations; thus, endoscopists are on the frontline of the diagnosis of GI-NETs. Since GI-NETs are less frequent than other malignancies, the natural history, diagnosis, and management of these tumors may not be fully understood. In this review, we aim to update the endoscopist on key clinical features and management of patients with gastric, duodenal, and rectal NETs.
Os tumores neuroendócrinos (TNE) são tumores raros derivados do sistema neuroendócrino e mais frequentemente encontrados no trato gastrointestinal. Nas últimas décadas, a incidência de TNEs gastrointestinais tem vindo a aumentar de forma consistente, em parte devido às crescentes indicações da endoscopia. De facto, a maioria dos doentes com TNEs são assintomáticos e a lesão é identificada durante procedimentos de rastreio. Os endoscopistas estão na linha de frente do diagnóstico destes tumores. Como os TNEs são menos frequentemente encontrados em comparação com outras neoplasias, a história natural, o diagnóstico e a abordagem terapèutica destes tumores podem não ser totalmente compreendidos. Nesta revisão, os autores têm como objetivo atualizar o endoscopista sobre as principais características clínicas e abordagem endoscópica de doentes com TNE gástricos, duodenais e rectais.
Keywords: Endoscopy; Gastrointestinal tract; Neuroendocrine tumors.
Copyright © 2021 by S. Karger AG, Basel.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures





Similar articles
-
Diagnosis and Management of Upper Gastrointestinal Neuroendocrine Tumors.Clin Endosc. 2017 Nov;50(6):520-529. doi: 10.5946/ce.2017.181. Epub 2017 Nov 30. Clin Endosc. 2017. PMID: 29207862 Free PMC article. Review.
-
Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China.Scand J Gastroenterol. 2019 Mar;54(3):384-389. doi: 10.1080/00365521.2019.1588367. Epub 2019 Apr 30. Scand J Gastroenterol. 2019. PMID: 31037980
-
Management of gastric and duodenal neuroendocrine tumors.World J Gastroenterol. 2016 Aug 14;22(30):6817-28. doi: 10.3748/wjg.v22.i30.6817. World J Gastroenterol. 2016. PMID: 27570419 Free PMC article. Review.
-
Evolving role of the endoscopist in management of gastrointestinal neuroendocrine tumors.World J Gastroenterol. 2017 Jul 21;23(27):4847-4855. doi: 10.3748/wjg.v23.i27.4847. World J Gastroenterol. 2017. PMID: 28785139 Free PMC article.
-
Systematic review: management of localised low-grade upper gastrointestinal neuroendocrine tumours.Aliment Pharmacol Ther. 2020 Jun;51(12):1247-1267. doi: 10.1111/apt.15765. Epub 2020 May 11. Aliment Pharmacol Ther. 2020. PMID: 32390152
Cited by
-
Endocrine and paracrine characteristics of neuroendocrine prostate cancer.Front Endocrinol (Lausanne). 2022 Nov 11;13:1012005. doi: 10.3389/fendo.2022.1012005. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36440195 Free PMC article.
-
EUS-guided glue injection for managing torrential bleeding during gastric neuroendocrine tumor endoscopic submucosal dissection: sealing the storm.VideoGIE. 2024 Jul 23;9(11):468-471. doi: 10.1016/j.vgie.2024.07.001. eCollection 2024 Nov. VideoGIE. 2024. PMID: 39534559 Free PMC article. No abstract available.
-
Pediatric Neuroendocrine Neoplasms: Rare Malignancies with Incredible Variability.Cancers (Basel). 2022 Oct 15;14(20):5049. doi: 10.3390/cancers14205049. Cancers (Basel). 2022. PMID: 36291833 Free PMC article. Review.
-
Cap-Assisted Endoscopic Mucosal Resection for Rectal Neuroendocrine Tumors: An Effective Option.GE Port J Gastroenterol. 2022 Aug 26;30(2):107-114. doi: 10.1159/000525964. eCollection 2023 Mar. GE Port J Gastroenterol. 2022. PMID: 37008522 Free PMC article.
-
Gastric Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm: An Unusual Tumor and Its Presentation in a Young Adult.GE Port J Gastroenterol. 2024 Mar 7;31(6):432-436. doi: 10.1159/000536674. eCollection 2024 Dec. GE Port J Gastroenterol. 2024. PMID: 39633910 Free PMC article.
References
-
- Niederle MB, Hackl M, Kaserer K, Niederle B. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer. 2010 Oct;17((4)):909–18. - PubMed
-
- Öberg K, Knigge U, Kwekkeboom D, Perren A, ESMO Guidelines Working Group Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012 Oct;23(Suppl 7):vii124–30. - PubMed
Publication types
LinkOut - more resources
Full Text Sources